"....However, in my opinion Zenith has a much more advanced program and is worth more....Morphosys is paying $34 per share to acquire Constellation, which represents a 68% premium to the stock’s closing price on Tuesday...."

Which means Constellation was trading at $20 prior.  Dunno what shares outstanding are, but anyhow, here we sit at 30 cents.